List of works - Richard Češka

The Residual Risk Reduction Initiative: a call to action to reduce residual vascular risk in patients with dyslipidemia

scientific article

Age and residual cholesterol efflux affect HDL cholesterol levels and coronary artery disease in ABCA1 heterozygotes.

scientific article

Statin intolerance - an attempt at a unified definition. Position paper from an International Lipid Expert Panel

scientific article

ODYSSEY FH I and FH II: 78 week results with alirocumab treatment in 735 patients with heterozygous familial hypercholesterolaemia

scientific article

The Residual Risk Reduction Initiative: a call to action to reduce residual vascular risk in dyslipidaemic patient

scientific article

Randomized, placebo-controlled trial of mipomersen in patients with severe hypercholesterolemia receiving maximally tolerated lipid-lowering therapy

scientific article

The use of statins in people at risk of developing diabetes mellitus: evidence and guidance for clinical practice.

scientific article published on June 2014

Eprotirome in patients with familial hypercholesterolaemia (the AKKA trial): a randomised, double-blind, placebo-controlled phase 3 study

scientific article published on 18 February 2014

Drug-drug interactions with statins: will pitavastatin overcome the statins' Achilles' heel?

scientific article published on 17 June 2011

Statin intolerance – an attempt at a unified definition. Position paper from an International Lipid Expert Panel

article

Cholesterol-lowering therapy evokes time-limited changes in serotonergic transmission

scientific article published in February 2005

Folate supplementation prevents plasma homocysteine increase after fenofibrate therapy.

scientific article published in September 2001

Statin Intolerance: the Clinician's Perspective

scientific article

Impact of apolipoprotein A5 variants on statin treatment efficacy

scientific article

Efficacy and safety of extended-release niacin/laropiprant plus statin vs. doubling the dose of statin in patients with primary hypercholesterolaemia or mixed dyslipidaemia.

scientific article published in May 2010

Oral but not transdermal estrogen replacement therapy changes the composition of plasma lipoproteins.

scientific article published in August 2008

Effect of simvastatin and fenofibrate on endothelium in Type 2 diabetes

scientific article

Serum leptin levels in patients with hyperlipidemias

scientific article published on 01 June 2000

Effect of folic acid on fenofibrate-induced elevation of homocysteine and cysteine.

scientific article

Hypertriglyceridemia: interaction between APOE and APOAV variants

scientific article

MLXIPL variant in individuals with low and high triglyceridemia in white population in Central Europe

article by Michal Vrablík et al published 23 October 2008 in Human Genetics

Ivabradine in Stable Coronary Artery Disease

scientific article published on December 18, 2014

FTO and MC4R gene variants determine BMI changes in children after intensive lifestyle intervention

article

Increased levels of pregnancy-associated plasma protein-A in patients with hypercholesterolemia: the effect of atorvastatin treatment.

scientific article

APOA5 Ala315>Val, identified in patients with severe hypertriglyceridemia, is a common mutation with no major effects on plasma lipid levels

scientific article

SLCO1B1 polymorphism is not associated with risk of statin-induced myalgia/myopathy in a Czech population

scientific article published on 20 May 2015

Increase of inflammatory state in overweight adults with combined hyperlipidemia.

scientific article

Atorvastatin reduces expression of leukocyte adhesion molecules in patients with hypercholesterolemia.

scientific article published in January 2003

Clinical implications of the metabolic syndrome

scientific article published on 01 September 2007

Gene variants at FTO, 9p21, and 2q36.3 are age-independently associated with myocardial infarction in Czech men

article

Nitroglycerin induced syncope occurs in subjects with delayed phase shift of baroreflex action.

scientific article

Association between polymorphism within the RYR2 receptor and development of statin-associated myalgia/myopathy in the Czech population

article

Detection of variability in apo(a) gene transcription regulatory sequences using the DGGE method

scientific article published on 21 July 2006

Decreasing common carotid artery intimal thickness during hypolipidemic therapy

scientific article published on 01 September 1997

Ivabradine, coronary heart disease, and heart failure: time for reappraisal.

scientific article published on December 2014

Flow-dependent vasomotor dysfunction of the popliteal artery related to common carotid artery intima-media thickness.

scientific article published in October 2001

PAPP-A, a novel marker of unstable plaque, is not influenced by hypolipidemic treatment in contrast to CRP.

scientific article published in January 2003

Statins, glycemia, and diabetes mellitus: another point of view

scientific article published on December 2014

The apo(a) gene (TTTTA)n promoter polymorphism and its association with variability in exons of the kringle IV types 8 to 10.

scientific article published on 5 April 2009

Plasma HDL-cholesterol and triglyceride levels in familial hypercholesterolemia: data from the MedPed CZ database and the Czech population.

scientific article

Folic acid does not improve surrogate markers of early atherosclerosis in atorvastatin-treated patients

3P-0742 APOAV polymorphisms (T-1131/C and Ser19/Trp) influence on plasma triglyceride levels and risk of myocardial infarction

article published in 2003

T04-P-048 Liprotein (a), its relation to plasmalipids and other risk factors for atherosclerosis

article published in 2005

Prevention of diabetes with rosiglitazone: Evidence of benefit or unexpected harm?

scientific article published on 12 September 2007

Dyslipidémie: doporučené diagnostické a terapeutické postupy pro všeobecné praktické lékaře 2017

book edition published in 2017

Interna

book edition published in 2015

ROSIGLITAZONE AND FENOFIBRATE IMPROVE HDL METABOLISM ASSESSED BY FERHDL

2P-0477 Leukocyte but not endothelial cell adhesion molecules are increased in patients with hypercholesterolemia: The effect of atorvastatin treatment

Q121966058

book edition published in 2015

List of works by Richard Češka

The Residual Risk Reduction Initiative: a call to action to reduce residual vascular risk in patients with dyslipidemia

Age and residual cholesterol efflux affect HDL cholesterol levels and coronary artery disease in ABCA1 heterozygotes.

Statin intolerance - an attempt at a unified definition. Position paper from an International Lipid Expert Panel

ODYSSEY FH I and FH II: 78 week results with alirocumab treatment in 735 patients with heterozygous familial hypercholesterolaemia

The Residual Risk Reduction Initiative: a call to action to reduce residual vascular risk in dyslipidaemic patient

Randomized, placebo-controlled trial of mipomersen in patients with severe hypercholesterolemia receiving maximally tolerated lipid-lowering therapy

The use of statins in people at risk of developing diabetes mellitus: evidence and guidance for clinical practice.

Eprotirome in patients with familial hypercholesterolaemia (the AKKA trial): a randomised, double-blind, placebo-controlled phase 3 study

Drug-drug interactions with statins: will pitavastatin overcome the statins' Achilles' heel?

Statin intolerance – an attempt at a unified definition. Position paper from an International Lipid Expert Panel

Cholesterol-lowering therapy evokes time-limited changes in serotonergic transmission

Folate supplementation prevents plasma homocysteine increase after fenofibrate therapy.

Statin Intolerance: the Clinician's Perspective

Impact of apolipoprotein A5 variants on statin treatment efficacy

Efficacy and safety of extended-release niacin/laropiprant plus statin vs. doubling the dose of statin in patients with primary hypercholesterolaemia or mixed dyslipidaemia.

Oral but not transdermal estrogen replacement therapy changes the composition of plasma lipoproteins.

Effect of simvastatin and fenofibrate on endothelium in Type 2 diabetes

Serum leptin levels in patients with hyperlipidemias

Effect of folic acid on fenofibrate-induced elevation of homocysteine and cysteine.

Hypertriglyceridemia: interaction between APOE and APOAV variants

MLXIPL variant in individuals with low and high triglyceridemia in white population in Central Europe

Ivabradine in Stable Coronary Artery Disease

FTO and MC4R gene variants determine BMI changes in children after intensive lifestyle intervention

Increased levels of pregnancy-associated plasma protein-A in patients with hypercholesterolemia: the effect of atorvastatin treatment.

APOA5 Ala315>Val, identified in patients with severe hypertriglyceridemia, is a common mutation with no major effects on plasma lipid levels

SLCO1B1 polymorphism is not associated with risk of statin-induced myalgia/myopathy in a Czech population

Increase of inflammatory state in overweight adults with combined hyperlipidemia.

Atorvastatin reduces expression of leukocyte adhesion molecules in patients with hypercholesterolemia.

Clinical implications of the metabolic syndrome

Gene variants at FTO, 9p21, and 2q36.3 are age-independently associated with myocardial infarction in Czech men

Nitroglycerin induced syncope occurs in subjects with delayed phase shift of baroreflex action.

Association between polymorphism within the RYR2 receptor and development of statin-associated myalgia/myopathy in the Czech population

Detection of variability in apo(a) gene transcription regulatory sequences using the DGGE method

Decreasing common carotid artery intimal thickness during hypolipidemic therapy

Ivabradine, coronary heart disease, and heart failure: time for reappraisal.

Flow-dependent vasomotor dysfunction of the popliteal artery related to common carotid artery intima-media thickness.

PAPP-A, a novel marker of unstable plaque, is not influenced by hypolipidemic treatment in contrast to CRP.

Statins, glycemia, and diabetes mellitus: another point of view

The apo(a) gene (TTTTA)n promoter polymorphism and its association with variability in exons of the kringle IV types 8 to 10.

Plasma HDL-cholesterol and triglyceride levels in familial hypercholesterolemia: data from the MedPed CZ database and the Czech population.

Folic acid does not improve surrogate markers of early atherosclerosis in atorvastatin-treated patients

3P-0742 APOAV polymorphisms (T-1131/C and Ser19/Trp) influence on plasma triglyceride levels and risk of myocardial infarction

T04-P-048 Liprotein (a), its relation to plasmalipids and other risk factors for atherosclerosis

Prevention of diabetes with rosiglitazone: Evidence of benefit or unexpected harm?

Dyslipidémie: doporučené diagnostické a terapeutické postupy pro všeobecné praktické lékaře 2017

Interna

ROSIGLITAZONE AND FENOFIBRATE IMPROVE HDL METABOLISM ASSESSED BY FERHDL

2P-0477 Leukocyte but not endothelial cell adhesion molecules are increased in patients with hypercholesterolemia: The effect of atorvastatin treatment

Q121966058

Apoe genotype is not associated with variations in bone mineral density